Rappta
Beat Steffen - Chairman
Marianne Uteng - Observer
Oncology
Helsinki, Finland
Rappta Therapeutics is a biopharmaceutical company developing a first-in-class series of anti-cancer molecular glues that reactivate protein phosphatase 2A (PP2A).